Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Topical Vancomycin for SSI Reduction in Neurosurgery
NCT02284126Phase 3Completed
- Sponsor
- Columbia University
- Start
- Oct 2014
- Primary completion
- Nov 2019
- Modality
- Cyclic Peptides, Antimicrobial Peptides, Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of vancomycin in surgical site infection (SSI), sponsored by Columbia University. Started Oct 2014; status: completed.
02
Drugs
vancomycin
03
Conditions
surgical site infection (SSI)
Beyond the preview
Go deeper on NCT02284126.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02284126.